Home > Publications database > Chemosensitivity-directed therapy compared to dacarbazine in chemo-naive advanced metastatic melanoma: a multicenter randomized phase-3 DeCOG trial > print

001     128702
005     20240228145547.0
024 7 _ |a 10.18632/oncotarget.18635
|2 doi
024 7 _ |a WOS:000412066700022
|2 WOS
024 7 _ |a altmetric:27977240
|2 altmetric
024 7 _ |a pmid:29100289
|2 pmid
037 _ _ |a DKFZ-2017-04717
082 _ _ |a 610
100 1 _ |a Ugurel, Selma
|b 0
245 _ _ |a Chemosensitivity-directed therapy compared to dacarbazine in chemo-naive advanced metastatic melanoma: a multicenter randomized phase-3 DeCOG trial
260 _ _ |a [S.l.]
|c 2017
|b Impact Journals LLC
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1533214901_14017
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
536 _ _ |a 319H - Addenda (POF3-319H)
|0 G:(DE-HGF)POF3-319H
|c POF3-319H
|f POF III
|x 0
588 _ _ |a Dataset connected to Web of Science, Web of Science, , CrossRef
700 1 _ |a Loquai, Carmen
|b 1
700 1 _ |a Terheyden, Patrick
|b 2
700 1 _ |a Schadendorf, Dirk
|0 P:(DE-HGF)0
|b 3
700 1 _ |a Richtig, Erika
|b 4
700 1 _ |a Utikal, Jochen
|0 P:(DE-He78)a229f7724466e7efadf4a1ace1ff8af3
|b 5
700 1 _ |a Gutzmer, Ralf
|b 6
700 1 _ |a Rass, Knuth
|b 7
700 1 _ |a Sunderkötter, Cord
|b 8
700 1 _ |a Stein, Annette
|b 9
700 1 _ |a Fluck, Michael
|b 10
700 1 _ |a Kaatz, Martin
|b 11
700 1 _ |a Trefzer, Uwe
|b 12
700 1 _ |a Kähler, Katharina
|b 13
700 1 _ |a Stadler, Rudolf
|b 14
700 1 _ |a Berking, Carola
|b 15
700 1 _ |a Höller, Christoph
|b 16
700 1 _ |a Kerschke, Laura
|0 P:(DE-HGF)0
|b 17
700 1 _ |a Edler, Lutz
|0 P:(DE-He78)621efe295db6fdfa7f9f95011a5ea943
|b 18
700 1 _ |a Kopp-Schneider, Annette
|0 P:(DE-He78)bb6a7a70f976eb8df1769944bf913596
|b 19
700 1 _ |a Becker, Jürgen C.
|0 P:(DE-HGF)0
|b 20
773 _ _ |a 10.18632/oncotarget.18635
|g Vol. 8, no. 44, p. 76029 - 76043
|0 PERI:(DE-600)2560162-3
|n 44
|p 76029 - 76043
|t OncoTarget
|v 8
|y 2017
|x 1949-2553
909 C O |p VDB
|o oai:inrepo02.dkfz.de:128702
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 3
|6 P:(DE-HGF)0
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 5
|6 P:(DE-He78)a229f7724466e7efadf4a1ace1ff8af3
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 17
|6 P:(DE-HGF)0
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 18
|6 P:(DE-He78)621efe295db6fdfa7f9f95011a5ea943
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 19
|6 P:(DE-He78)bb6a7a70f976eb8df1769944bf913596
913 1 _ |a DE-HGF
|l Krebsforschung
|1 G:(DE-HGF)POF3-310
|0 G:(DE-HGF)POF3-319H
|2 G:(DE-HGF)POF3-300
|v Addenda
|x 0
|4 G:(DE-HGF)POF
|3 G:(DE-HGF)POF3
|b Gesundheit
914 1 _ |y 2017
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b ONCOTARGET : 2015
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0310
|2 StatID
|b NCBI Molecular Biology Database
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Thomson Reuters Master Journal List
915 _ _ |a WoS
|0 StatID:(DE-HGF)0111
|2 StatID
|b Science Citation Index Expanded
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
915 _ _ |a IF >= 5
|0 StatID:(DE-HGF)9905
|2 StatID
|b ONCOTARGET : 2015
920 1 _ |0 I:(DE-He78)G300-20160331
|k G300
|l KKE Dermatoonkologie
|x 0
920 1 _ |0 I:(DE-He78)C060-20160331
|k C060
|l Biostatistik
|x 1
920 1 _ |0 I:(DE-He78)L401-20160331
|k L401
|l DKTK Essen
|x 2
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)G300-20160331
980 _ _ |a I:(DE-He78)C060-20160331
980 _ _ |a I:(DE-He78)L401-20160331
980 _ _ |a UNRESTRICTED

LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21